Literature DB >> 20688883

Associations between serum leptin level and bone turnover in kidney transplant recipients.

Csaba P Kovesdy1, Miklos Z Molnar, Maria E Czira, Anna Rudas, Akos Ujszaszi, Laszlo Rosivall, Miklos Szathmari, Adrian Covic, Andras Keszei, Gabriella Beko, Peter Lakatos, Janos Kosa, Istvan Mucsi.   

Abstract

BACKGROUND AND OBJECTIVES: Obesity is associated with increased parathyroid hormone (PTH) in the general population and in patients with chronic kidney disease (CKD). A direct effect of adipose tissue on bone turnover through leptin production has been suggested, but such an association has not been explored in kidney transplant recipients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study examined associations of serum leptin with PTH and with biomarkers of bone turnover (serum beta crosslaps [CTX, a marker of bone resorption] and osteocalcin [OC, a marker of bone formation]) in 978 kidney transplant recipients. Associations were examined in multivariable regression models. Path analyses were used to determine if the association of leptin with bone turnover is independent of PTH.
RESULTS: Higher leptin levels were associated with higher PTH and lower vitamin D levels, and adjustment for vitamin D attenuated the association between leptin and PTH. However, higher leptin was also significantly associated with lower levels of the bone turnover markers: 1 SD higher leptin was associated with 0.13 lower log-OC (-0.17, -0.08, P < 0.001) and 0.030 lower log-CTX (-0.045, -0.016, P < 0.001) after multivariable adjustments. Path analysis indicated that the association of leptin with PTH was mostly mediated through vitamin D, and that the association between leptin and bone turnover was independent of PTH and vitamin D.
CONCLUSIONS: Elevated leptin level is associated with lower bone turnover independent of its effects on serum PTH in kidney transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688883      PMCID: PMC2994092          DOI: 10.2215/CJN.03520410

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  47 in total

1.  Racial differences in parathyroid hormone dynamics.

Authors:  G E Fuleihan; C M Gundberg; R Gleason; E M Brown; M E Stromski; F D Grant; P R Conlin
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

Review 2.  Clinical review 94: What's in a name? In search of leptin's physiologic role.

Authors:  J S Flier
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

3.  Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations.

Authors:  A Torres; A P Rodríguez; M T Concepción; S García; M Rufino; B Martín; L Pérez; M Machado; E de Bonis; M Losada; D Hernández; V Lorenzo
Journal:  Nephrol Dial Transplant       Date:  1998       Impact factor: 5.992

4.  The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure.

Authors:  I Martinez; R Saracho; J Montenegro; F Llach
Journal:  Am J Kidney Dis       Date:  1997-04       Impact factor: 8.860

5.  Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.

Authors:  P Ureña; M Hruby; A Ferreira; K S Ang; M C de Vernejoul
Journal:  J Am Soc Nephrol       Date:  1996-03       Impact factor: 10.121

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Adynamic bone lesion in renal transplant recipients with normal renal function.

Authors:  F Velasquez-Forero; A Mondragón; B Herrero; J C Peña
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

8.  Intact parathyroid hormone levels in renal insufficiency.

Authors:  V T Fajtova; M H Sayegh; N Hickey; P Aliabadi; J M Lazarus; M S LeBoff
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

9.  Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.

Authors:  A St John; M B Thomas; C P Davies; B Mullan; I Dick; B Hutchison; A van der Schaff; R L Prince
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes.

Authors:  T Thomas; F Gori; S Khosla; M D Jensen; B Burguera; B L Riggs
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

View more
  13 in total

1.  Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients.

Authors:  Katalin Fornadi; Anett Lindner; Maria E Czira; Andras Szentkiralyi; Alpar S Lazar; Rezso Zoller; Csilla Z Turanyi; Orsolya Veber; Marta Novak; Istvan Mucsi; Miklos Z Molnar
Journal:  Int Urol Nephrol       Date:  2011-12-06       Impact factor: 2.370

Review 2.  The intriguing connections of leptin to hyperparathyroidism.

Authors:  Stergios A Polyzos; Leonidas Duntas; Jens Bollerslev
Journal:  Endocrine       Date:  2017-07-20       Impact factor: 3.633

3.  Serum erythropoietin level and mortality in kidney transplant recipients.

Authors:  Miklos Z Molnar; Adam G Tabak; Ahsan Alam; Maria E Czira; Anna Rudas; Akos Ujszaszi; Gabriella Beko; Marta Novak; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-06       Impact factor: 8.237

4.  The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.

Authors:  Joo-Pin Foo; Stergios A Polyzos; Athanasios D Anastasilakis; Sharon Chou; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2014-08-22       Impact factor: 5.958

5.  Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Authors:  F Cortazar; M Z Molnar; T Isakova; M E Czira; C P Kovesdy; D Roth; I Mucsi; M Wolf
Journal:  Am J Transplant       Date:  2011-11-04       Impact factor: 8.086

6.  Red cell distribution width is associated with mortality in kidney transplant recipients.

Authors:  Istvan Mucsi; Akos Ujszaszi; Maria E Czira; Marta Novak; Miklos Z Molnar
Journal:  Int Urol Nephrol       Date:  2014-03       Impact factor: 2.370

7.  Depressive Symptoms Are Associated With Objectively Measured Sleep Parameters in Kidney Transplant Recipients.

Authors:  Katalin Z Ronai; Andras Szentkiralyi; Alpar S Lazar; Akos Ujszaszi; Csilla Turanyi; Ferenc Gombos; Istvan Mucsi; Robert Bodizs; Miklos Z Molnar; Marta Novak
Journal:  J Clin Sleep Med       Date:  2017-04-15       Impact factor: 4.062

Review 8.  Vitamin D and serum leptin: a systematic review and meta-analysis of observational studies and randomized controlled trials.

Authors:  M Hajimohammadi; S Shab-Bidar; T R Neyestani
Journal:  Eur J Clin Nutr       Date:  2016-12-14       Impact factor: 4.016

9.  Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients.

Authors:  K Turkmen; H Z Tonbul; F M Erdur; I Guney; H Kayikcioglu; L Altintepe; O Ozbek; M I Yilmaz; A Gaipov; S Turk; A Covic; M Kanbay
Journal:  Int Urol Nephrol       Date:  2012-09-23       Impact factor: 2.370

10.  Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue.

Authors:  Janet M Chiang; George A Kaysen; Anne L Schafer; Cynthia Delgado; Kirsten L Johansen
Journal:  J Ren Nutr       Date:  2018-03-29       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.